Navigation Links
Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease

trials for many devastating brain disorders," said Paul Greengard, PhD, chairman of the Neurologix Scientific Advisory Board and recipient of the 2000 Nobel Prize for Physiology or Medicine for his work related to how brain cells communicate. "The significant and sustained improvements in clinical symptoms following treatment of only one side of the brain are impressive. Moreover, the PET results offer an important window into the function of the living brain in these patients, which supports a normalization of brain activity specific to the treated hemisphere."

The study used an adeno-associated virus (AAV) vector to deliver an inhibitory gene (glutamic acid decarboxylase or "GAD") to the subthalmic nucleus (STN) of the brain. In Parkinson's disease, STN activity is abnormally increased, largely due to a deficit in GABA (gamma-aminobutyric acid), the major inhibitory neurotransmitter in the brain. Increasing GAD causes more GABA to be synthesized, thus helping to calm the STN over-activity. The value of this strategy has been demonstrated in previous human studies where reducing STN activity by either electrical stimulation or lesioning can help ameliorate the symptoms of advanced Parkinson's disease.

The Phase 1 study was not specifically designed to assess efficacy. Nonetheless, the researchers reported the clinical outcomes to be very encouraging, with treated patients showing significant improvement in both the "on" and "off" states of their illness (the time periods in which they achieve or do not realize benefit from drug therapy) beginning at three months following surgery and continuing through the end of the study. These improvements occurred predominantly on the side of the body corresponding to the side of the brain receiving treatment. Moreover, the absence of change at the earliest time point following treatment suggests that the improvement was not likely due to the surgical lesioning of the targeted brain region, as surgical approaches
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Neurologix to Present at the Third Annual C.E. Unterberg Towbin Emerging Growth Conference
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:5/17/2013)... Medical devices are any medical items that ... light of their different mechanisms, actions and regulatory requirements, ... than drug trails due to their unique clinical practices. ... evaluating both safety and efficacy (which is left to ... same as the SFDA) evaluate MDs for both safety ...
(Date:5/17/2013)... and CAMBRIDGE, Mass., May 17, 2013   Shareholder rights ... of Aveo Pharmaceutical, Inc. (NASDAQGS: AVEO) securities has filed ... District of Massachusetts .  The complaint ... the Securities Exchange Act of 1934 (the "Exchange Act") ... "Class Period"). (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ) ...
(Date:5/17/2013)... , May 17, 2013  TechAtlas Group ... for their competitive landscape map for the Chronic ... over 90 international companies with drugs and devices ... CKD and its sequelae. (Logo:  ... , hypertension - renal denervation ...
Breaking Medicine Technology:Statistical Challenges in Medical Device Trail Evaluation 2Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2
... 2012  Regado Biosciences, Inc., a privately held company leading ... announced that David J. Mazzo, PhD, President and CEO, ... at 9:15 a.m. local time (3:15 a.m. EDT) on ... in Amsterdam, The Netherlands. The presentation will ...
... Fla., March 14, 2012  Nutra Pharma Corporation (OTCBB: NPHC), ... Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and ... an outside branding and marketing firm to aid in ... "We are excited to be working with ...
Cached Medicine Technology:Regado Biosciences, Inc. to Present at the BIO-Europe Spring® 2012 Conference in Amsterdam, The Netherlands 2Regado Biosciences, Inc. to Present at the BIO-Europe Spring® 2012 Conference in Amsterdam, The Netherlands 3Nutra Pharma Engages Marketing Firm for the Branding and Channel Development of Nyloxin™ 2Nutra Pharma Engages Marketing Firm for the Branding and Channel Development of Nyloxin™ 3
(Date:5/18/2013)... The Communities of Distinction TV ... call home. These are the townships, villages and other small ... where the people are friendly and neighbors are there when ... highways and shares the best in both the United States ... American sports and film celebrity. It airs in May and ...
(Date:5/18/2013)... May 18, 2013 Family Magazine of Washington ... excellence by Follow Media Consulting, Inc. in the category of ... continued commitment and dedication of the areas best in the ... one knows parenting better than Brenda Hyde, a mother of ... help parents know about the vast resources available to them ...
(Date:5/18/2013)... May 18, 2013 The “Sleep Apnea ... Oximeters, CPAP, Masks, Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal ... to 2017” analyzes and studies the major market drivers, ... Rest of the World. , Browse , ... 16 Figures , 318 pagesand ...
(Date:5/18/2013)... The California College of Ayurveda Spa ... Ayurvedic Spa , the client receives stress relief ... and lifestyle recommendations and stress management techniques by a ... the traditional healthcare system of India. It is based ... the basis for all optimum health. Ayurveda believes that ...
(Date:5/18/2013)... Ohio (PRWEB) May 18, 2013 ... Annual Conference, on May 17-22 in Austin, TX ... gather for educational and networking opportunities. , ... brushes, flexible scope repair capabilities and ... with valuable educational information on proper instrument care ...
Breaking Medicine News(10 mins):Health News:Communities of Distinction TV Presents "A Place to Call Home" Segment 2Health News:Summer Camps in DC "Best of the Best" Awarded to Family Magazine of Washington DC for Excellence by Follow Media Consulting, Inc. 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3Health News:Ayurveda Spa Treatments Now Offered at the California College of Ayurveda Panchakarma Center 2Health News:Spectrum Surgical Attends Society of Gastroenterology Nurses and Associates' (SGNA) 40th Annual Conference in Austin, TX 2
... new project is an interdisciplinary research project covering ... has been awarded EUR 6 million from the ... The project will gather scientists from seven countries, ... University of Gothenburg, Sweden. , Those working on ...
... more quickly and consistently WASHINGTON, May 26 As ... outbreak, many U.S. school and government leaders used notification ... updates and information - the latest example of the ... days when it might have taken officials days to ...
... helps explain association between the two illnesses , , TUESDAY, ... gum disease (periodontitis) and heart disease has been discovered ... coronary heart disease (CHD) has been known for years, ... confirmed. The University of Kiel team found that the ...
... in just four days, the mobile cloud computing solution shortens ... just two hoursSAN FRANCISCO, May 26 Salesforce.com (NYSE: ... that RehabCare Group, Inc. (NYSE: RHB ) has ... to run on its staff,s Apple iPhones. Built in ...
... immediate need to integrate our internal applications more robustly and ... testing, and deploying new interfaces within our timelines. , ... ... -- Seattle Radiologists APC, a regional, high volume, radiology group ...
... LONDON, May 26 The European prebiotics ... importance and value throughout the food and ... infant formula products, dairy and beverages and ... application sectors such as snack products and ...
Cached Medicine News:Health News:Sahlgrenska Academy to lead major European project on obesity 2Health News:Schools and Cities Send 9.7 Million Messages During Swine Flu Outbreak with Blackboard Connect(TM) Platform 2Health News:Schools and Cities Send 9.7 Million Messages During Swine Flu Outbreak with Blackboard Connect(TM) Platform 3Health News:Schools and Cities Send 9.7 Million Messages During Swine Flu Outbreak with Blackboard Connect(TM) Platform 4Health News:Gum Disease, Heart Disease Share Genetic Link 2Health News:RehabCare Leverages Force.com Platform to Build Custom Healthcare Application for use on Apple iPhone 2Health News:RehabCare Leverages Force.com Platform to Build Custom Healthcare Application for use on Apple iPhone 3Health News:RehabCare Leverages Force.com Platform to Build Custom Healthcare Application for use on Apple iPhone 4Health News:Seattle Radiologists Raise Workflow Performance and Results with Corepoint Integration Engine 2Health News:Seattle Radiologists Raise Workflow Performance and Results with Corepoint Integration Engine 3Health News:Seattle Radiologists Raise Workflow Performance and Results with Corepoint Integration Engine 4Health News:European Prebiotics Market Diversifies Strongly Across New Application Sectors in Food and Beverage Industry, Finds Frost & Sullivan 2Health News:European Prebiotics Market Diversifies Strongly Across New Application Sectors in Food and Beverage Industry, Finds Frost & Sullivan 3Health News:European Prebiotics Market Diversifies Strongly Across New Application Sectors in Food and Beverage Industry, Finds Frost & Sullivan 4Health News:European Prebiotics Market Diversifies Strongly Across New Application Sectors in Food and Beverage Industry, Finds Frost & Sullivan 5Health News:European Prebiotics Market Diversifies Strongly Across New Application Sectors in Food and Beverage Industry, Finds Frost & Sullivan 6Health News:European Prebiotics Market Diversifies Strongly Across New Application Sectors in Food and Beverage Industry, Finds Frost & Sullivan 7
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: